Survey of oxaliplatin-associated peripheral sensory neuropathy using an interview-based questionnaire in patients with advanced colorectal cancer

Japanese Journal of Cancer and Chemotherapy

Volumn 36, Issue 8, 2009, Pages 1321-1325

  Satomi, Machiko ^a   Kono, Toru ^b   Mamiya, Noriaki ^a,b   Chisato, Naoyuki ^b   Ebisawa, Yoshiaki ^b   Sugawara, Mutsubu ^a,b   Saito, Takashige ^a   Matsubara, Kazuo ^b   Kasai, Shinichi ^b  

^a Higashiasahikawa Hospital   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Interview based intake; Oxaliplatin; Peripheral sensory neuropathy

Indexed keywords

FLUOROURACIL; OXALIPLATIN;

ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; DIABETES MELLITUS; DISEASE SEVERITY; FINGER; HEALTH SURVEY; HUMAN; INTERVIEW; NEUROTOXICITY; RETROSPECTIVE STUDY; SENSORY NEUROPATHY; TOE; TONGUE;

EID: 79959858740     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Kim GP and Erlichman C: Oxaliplatin in the treatment of colorectal cancer. Expert Opin Drug Metab Toxicol 3: 281-294, 2007.
2. Pasetto LM, D'Andrea MR, Rossi E, et al: Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol 59: 159-168, 2006.
3. Cersosimo RJ: Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 39: 128-135, 2005.
4. Grothey A: Clinical management of oxaliplatin-associated neurotoxicity. Clin Colorectal Cancer 5(Suppl 1): S38-46, 2005.
5. Cassidy J and Misset JL: Oxaliplatin-related side effects: characteristics and management. Semin Oncol 29: 11-20, 2002.
6. Shimizu T, Satoh T, Tamura K, et al: Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience. Int J Clin Oncol/Jpn Soc Clin Oncol 12: 218-223, 2007.
7. Grothey A: Oxaliplatin-safety profile: neurotoxicity. Semin Oncol 30: 5-13, 2003.
8. Andre T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343-2351, 2004. (Pubitemid 38702845)